FluLaval Only Pediatric Flu Vaccine Available Through VFC: Now Can Be Administered to Children 6 Months and Older

On November 18, 2016, the Food and Drug Administration approved an extension of the age range of quadrivalent FluLaval IIV to include children 6 through 35 months of age. FluLaval was previously approved for people 3 years of age and older.  The vaccine will be supplied by VFC for this indication in multi-dose vials. The dosage approved for children 6 through 35 months of age is 0.5 mL – the same dosage as for people 3 years of age and older.

ACIP has not yet issued a recommendation regarding the use of FluLaval in children 6 through 35 months of age. However, clinicians are free to use this and other vaccines in a manner consistent with their FDA labeling.  More information about FluLaval® and the updated recommendation can be found on the GSK Website.

Click here to download this message as a pdf